TrialNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2019

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia.

Geoffrey A Block et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.